EuroCVP 2021 was held online and gave the best from our longstanding "All About Clinical Trials" course, to improve skills in designing and planning successful clinical trials. Moreover, profound discussions and expert panels enriched the record-breaking "Pharmacotherapy in Older People" course, to deliver better, personalised therapy for older patients. In addition to the highly successful course program, the designated highlight sessions provided an overview on pharmacotherapy and COVID-19, current challenges in pharmacogenomics, or on how to manage post-operative anti-thrombotic therapy after cardiovascular surgery.
Thank you for attending EuroCVP 2021.
From the Committee
In this unusual year in which many scientific conferences have been cancelled or switched from face-to-face meetings to virtual meetings due to the coronavirus pandemic, the ESC Working Group on Cardiovascular Pharmacotherapy was pleased to organise the virtual edition of the EuroCVP 2021.
In edition to this, the programme's main sessions dealt with all of the most recent updates in the field, including a focus on pharmacotherapy and covid-19 (session 10), current challenges in pharmacogenomics (session 3), how to manage post-operative anti-thrombotic therapy after cardiovascular surgery (session 4)...
The scientific committee comprised the following members of the nucleus of the ESC Working Group on Cardiovascular Pharmacotherapy
Dr. Patrick Sulzgruber, Course Coordinator
Prof. Alexander Niessner, Austria, WG Chairperson
Prof. Heinz Drexel, Austria, WG Past Chairperson
Prof. Juan Carlos Kaski, UK, WG Chairperson-Elect
Prof. Sven Wassmann, Germany
Prof. Gianluigi Savarese, Sweden
Prof. Juan Tamargo, Spain
Become a member
This course is organised by the ESC Working Group on Cardiovascular Pharmacotherapy.
Not a member yet? Join today for free
Plaza de Europa, 17-19
08908 L’Hospitalet de Llobregat
Please do not hesitate to contact the ESC Working Groups department for more information.